'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Reference
BSAVA’s client information leaflets are designed to be used as part of the veterinary consultation and provide information to help owners understand what is involved in a procedure or examination, including the reasons for it, the preparation required, any associated risks and what happens during and after the procedure.
They are available in a PDF format which can be printed and stamped with the veterinary practice details or emailed to clients.
Elise Robertson, ABVS American Board-Certified Diplomate Feline Practice and author of the endoscopic Client Information Leaflets, said: ‘The client information leaflets were created due to the need for accurate and reliable information from reputable sources."
BSAVA’s Head of Publishing, Ian Mellor, said: "This new factsheet brings our total number of client leaflets to 178. Our client leaflets have been downloaded more than 10,000 times in the past year and are an important part of our drive to improve the health and welfare of small animals by providing practical resources to the veterinary profession.’
The new leaflet is available via the BSAVA Library (https://www.bsavalibrary.com/content/cilgroupprocedures).
Access to the entire range of client information leaflets (including canine and feline behaviour, exotic pets and medicines) is available for an annual subscription of £40; BSAVA members have access to these leaflets as one of their membership benefits.
BSAVA welcomes suggestions for new topics to cover in its client information leaflets.
Send your ideas to publications@bsava.com.
The webinar will take place at 11am and will be repeated at 7.30pm for those who are unable to listen during the day.
Hosted by Zoetis vet Dr Wendy Talbot the session will last for approximately an hour and equates to 8 AMTRA CPD points.
Wendy will explain the current situation and recommended approaches to help slow resistance.
The webinar will conclude with a live Q&A to give everyone the opportunity to discuss any queries, concerns or common questions they hear from their customers with Wendy.
Zoetis Equine Product Manager, Penny McCann said: "Our webinars continue to be very well received.
“This one is particularly important as it explains the important new thinking around the use of anthelmintics in order to address the serious challenge of resistance.
"It’s a must for all those involved with prescribing.”
To book the 11am webinar: https://register.gotowebinar.com/register/6163460189961597967 To book the 7.30pm webinar: https://register.gotowebinar.com/register/6394015684169009164
Those veterinary surgeons being audited are being asked to share their records for 2013 to 2015 by either allowing the College to access their online Professional Development Record or by sending the RCVS a copy of their CPD record cards. The deadline for sharing records is Friday 14 October 2016.
The audit is focused on six groups:
If any of the veterinary surgeons who have been audited are found to be non-compliant (ie. less than 105 hours of CPD over a rolling three-year period), they will be asked to explain why and send a plan stating how they will make up the hours in order to become compliant.
The College says it is also keen to remind veterinary surgeons that CPD encompasses a wide range of recorded activities, which can be clinical or non-clinical, including private reading/study, webinars, mentoring, clinical audit and discussion groups as well as attending seminars and workshops.
More information about what counts as CPD can be found at www.rcvs.org.uk/cpd
Those with any questions about the auditing process or what constitutes CPD can contact Jenny Soreskog-Turp, Education Officer at the College, on cpd@rcvs.org.uk
Ed's note: Don't forget to claim your VetSurgeon.org CPD certificate detailing time you've recorded reading content and taking part in qualifying discussions on the site. Click 'My Account' and then the 'CPD' tab to view your records and create your certificate.
The strategy, which is available to read at: www.rcvs.org.uk/diversity, lists six areas where the College and other DIG member organisations can work to improve diversity and inclusion within the veterinary professions at all stages – from school-age children who may be considering a career in the veterinary professions, to engendering positive culture change for those already in the professions.
The six areas are:
The RCVS Diversity & Inclusion Group includes representation from the Association of Veterinary Students (AVS), British Veterinary Association (BVA), the British Veterinary Ethnicity & Diversity Society (BVEDS), the British Veterinary LGBT+ Society, the British Veterinary Nursing Association (BVNA), the Major Employers Group, the Society of Practising Veterinary Surgeons (SPVS) and the Veterinary Schools Council (VSC) and will be responsible for monitoring and evaluating progress within each of the above areas.
Dr Niall Connell, Senior Vice-President of the RCVS and Chair of the Diversity & Inclusion Group, said: "I’ve always been of the opinion that making the veterinary professions more diverse and reflective of British society at large, as well as protecting fellow professionals from discrimination, isn’t just a moral issue, but one that actually improves the quality of the profession and the outcomes we are delivering for our clients and patients.
"If we are losing colleagues to discrimination or just not attracting people from diverse backgrounds in the first place because they think it’s ‘not for people like them’, then we are losing out as a profession, and if we aren’t drawing on a diverse range of backgrounds, experiences, and attitudes in our work, then we are also potentially doing a disservice to our patients and clients. This is why this Strategy is not just a case of being seen to be doing something, but is actually crucial for the ongoing vitality and credibility of the veterinary team.
"It’s important to emphasise that this Strategy is a start, and not an end in and of itself. There will be lots of hard work to be done and challenging conversations to be had, and results may not be quick or immediately obvious, but I am proud that we are taking a proactive approach and not just saying ‘things will change with time’.
Dr Mandisa Greene, RCVS President and a member of the DIG, added: “Fulfilling this Strategy will involve a lot of hard work over the coming months and years but I am glad to say that many of the activities it outlines are already underway both at the RCVS and our partner organisations, building on the pioneering work that organisations such as the British Veterinary Association, British Veterinary Ethnicity & Diversity Society, the British Veterinary LGBT+ Society, Animal Aspirations and others have been undertaking.
“For example, we have already held a joint RCVS and Veterinary Schools Council Roundtable with BAME students in which we heard about their experiences, issues that they have encountered and how they felt they could be better supported. These discussions led to the formation of a new RCVS/VSC Working Group that will take forward actions as a priority.
"Our Mind Matters Initiative has also funded a vital piece of research being undertaken by BVEDS and the Royal Veterinary College on the impact of racism on the mental health of BAME veterinary professionals which will no doubt highlight some critical actions to take to better protect members of the professions from discrimination and improve how discrimination is reported and dealt with.
“On a personal level, I have also been undertaking a number of school talks and providing one-to-one mentoring to school students about veterinary careers because I think it is important that children from a wide variety of backgrounds can see me, as a Black British woman of Caribbean heritage, as a role-model for diversity within the veterinary profession and know that the professions can and should be welcoming to all.”
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
The research was carried out by the Kansas State University College of Veterinary Medicine Center for Outcomes Research and Epidemiology, Holland Management Services, Zoetis and the Pet Insight Project team at Kinship (part of Mars Petcare).
For the study, researchers recorded pet scratching activity use Whistle canine activity trackers. They then compared that information with the visual observations of 358 pet owners who graded the severity of their pet’s scratching activity on a scale from 0, which represents a normal dog (“itching is not a problem for my dog”) to 100, corresponding to extreme itching (“itching disrupts my dog’s sleep, eating, play and exercise”).
The researchers found that measurements of scratching severity determined by the Whistle activity tracker corresponded to the owner’s overall impression of the pet’s pruritus, or itch, level. As scratching severity increased, as measured by the Whistle device, owner’s assessment scores significantly increased as well (P < 0.01).
Aletha Carson DVM, Data and Clinical Studies Senior Manager for Kinship said: “Pet owners can overlook the subtle changes in behaviour that may be a warning sign for an underlying issue and are often too late to recognise their beloved companion is suffering.
“This new method of analysing pet behaviours provides pet owners with an ‘always-on’ monitor that may be helpful in keeping their dogs healthy and happy.
“It may also prove to be quite useful for veterinarians who need an objective way to gauge a pet’s response to prescribed therapies used to reduce inflammation and scratching without requiring time-intensive monitoring from the owner.”
Details of the research were shared at the European Veterinary Dermatology Congress on September 17, 2021.
The procedure involves introducing a catheter through the jugular, then using fluoroscopy and transoesophageal echocardiography to guide it from the right atrium through to the left side of the heart to relieve abnormal high pressures in the left atrium.
Willows says it is one of only a few centres across Europe equipped to carry out the procedure and that typically, patients who undergo TSP can be discharged from hospital the day after surgery.
Fabio Sarcinella (pictured right), an RCVS and European specialist in small animal cardiology at Willows, said: “Early clinical evaluation of the TSP procedure in humans over the last few years has shown improved quality of life and reduced clinical signs in patients with heart failure.
“The procedure has also been associated with low-risk and a meaningful drop in left atrial pressure of the affected patients.”
Fabio added: “As well as being minimally invasive, the improvement in heart chamber pressures via TSP often allows for a reduction in the dose of water tablets which are used to control the heart failure signs in the lungs.
"Lowering the dose reduces the risk of side effects related to these drugs such as kidney failure.”
Willows says TSP is most commonly used for left atrial decompression in dogs with heart failure and concurrent renal disease or that have advanced heart failure but continue to have symptoms despite optimal medical treatment.
www.willows.uk.net
The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.
Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.
Responses must be submitted before 23:59 on 26th September 2025
https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey
BPEX is looking for a few more veterinary surgeons to test its Real Welfare smartphone app, which is used to collect data regarding welfare outcomes in pigs.
BPEX says it will pay vets for their time carrying out the testing but it needs regular submissions of data to give both Android and iOS a good workout.
Project Manager Katja Stoddart said: "It has been a long and sometimes difficult journey but the app is now performing well on both platforms and we are receiving positive feedback from those using it.
"That does not mean there are no problems but those that do crop up are now minor and can easily be dealt with.
"We still need a handful more vets willing to do the testing but we must stress we need regular data submission to make it worthwhile."
Ultimately the app will replace the bureau service which has only been extended until the end of this year so vets will need to change over before the bureau closes.
Katja said the portal will continue so vets can do the assessments in paper form then transfer via a computer but it will be much quicker and easier in the long run to input in real time using the app.
She added: "This will also mean the data is available immediately for the vet to discuss with the producer."
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora
The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
Presented by Andy Moores and Alex Belch, 'Plates and Screws - An Introduction' is aimed at surgeons with no prior experience of applying plates and screws, and offers seven hours of CPD.
Andy said: "If you've ever wondered if orthopaedics is for you, or you just need an introductory course to get you started, this could be the perfect opportunity.
"The course should be particularly useful for junior colleagues: the tutors are very friendly and it's great value thanks to sponsorship from Veterinary Instrumentation and the BVOA.
Tickets cost £200 (plus £40 for non-members): https://bvoa.co.uk/wp-content/uploads/2023/07/Plating-registration-form.pdf
The BVOA 60th Anniversary Conference follows from 12th-14th October at the same venue.
Titled "Back to the Future, the conference features talks by Mike Farrell, Antonio Pozzi, Stuart Carmichael and others, covering subjects such as fracture repair, joint pathology, imaging techniques and osteoarthritis.
There'll also be a chance to look round HMS Belfast, and a gala black tie dinner.
Tickets start at £250 for a single day, up to £795 for the full conference package.
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
Boehringer Ingelheim Vetmedica has launched new, more palatable Metacam Chewable Tablets.
According to the company, the tablets are proven to be taken by 90% of dogs voluntarily1 and 80% will even take them from the floor1 which aids compliance. Available in pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range.
Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, said: "The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising 'beefed up' meaty flavour."
For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959.
The materials include a 15-minute video in which Sarah (pictured right) gives her advice on the medical management of hyperthyroid cases. She also introduces Thiamacare, Animalcare's high strength (10mg/ml) thiamazole oral solution, launched by the company last year.
Sarah has also helped to produce an in-clinic infographic which offers practical tips on handling hyperthyroid cats in order to minimise stress, as low-stress handling is known to help benefit treatment outcomes. The infographic also contains tips for owners on transporting cats, gives advice to practices on how to make waiting rooms and consult rooms cat-friendly and suggests considerations for blood-sampling and therapeutic assistance.
The materials are all available free of charge from www.the-pac.co.uk
James Beaumont, Brand Manager, said: ‘’Hyperthyroid cats can be challenging to treat and to handle. We hope the educational resources we have developed with Dr Caney will support practice teams in strengthening the management of these cases, ensuring higher welfare for affected cats and supporting the human-companion animal bond.”
For more information, email: animalcare@animalcare.co.uk or telephone 01904 487687.
If you're attending BEVA this September you can win a place on the CEVA-sponsored Equine Ski-PD break in January 2010, combining a couple of days of first class Continued Professional Development (CPD) with some excellent skiing in the Italian Alps.
The course runs from 13-17 January 2009 and the CPD will be spread over five sessions, equating to two-and-a-half days. Equine vets Jane Boswell, Henry Tremaine, Professor Bruce McGorum, Professor Peter Clegg and Dr Tim Brazil will cover the topics of tendonitis, wound management, ophthalmology, internal medicine and joint disease.
Skiing will be at Courmayeur, a traditional Alpine village on the Italian side of Mont Blanc, where all levels of ability, from beginners to experienced off-piste skiers, can be catered for.
To win your place, which includes flights and four nights b&b accommodation, simply visit the CEVA stand at BEVA and answer a questionnaire on Tildren®, CEVA's bisphosphonate-based treatment for equine bone disease, based on information provided via a short film loop that will be running on the stand.
For further information on equine Ski-PD contact the organisers: ben.mayes@equinevetpractice.co.uk or henry.tremaine@bristol.ac.uk
The Disciplinary Committee of the RCVS has approved an application for restoration to the Register from an Oxfordshire veterinary surgeon who had been struck off for false certification.
In November 2007, the Committee decided that Mr John Williams, of the Avonvale Veterinary Practice in Ratley, near Banbury, should have his name removed from the RCVS Register, having found him guilty of disgraceful professional conduct. Mr Williams had admitted signing export health certificates for three horses in October 2006 to state that they had received negative test results for the contagious equine metritis organism, before these results were actually available.
At the time, Mr Williams was working in his capacity as an Official Veterinarian (OV) for DEFRA and he had previously been suspended from his official duties on three separate occasions, on the basis of export certification irregularities. It was accepted that Mr Williams had not been dishonest, but his approach to certification was described by the Disciplinary Committee as "either irresponsible or cavalier or both".
In December 2007, Mr Williams appealed against this decision to the Privy Council but this was dismissed at a Hearing the following June. He was then removed from the Register in July 2008.
When the Committee met on Monday to consider Mr Williams' application, they heard oral and written supporting evidence from veterinary surgeons and equine clients, and oral evidence from Mr Williams himself. The Committee was satisfied that Mr Williams accepted its previous findings and fully understood their seriousness. He described his removal from the Register as a "salutary experience" which had been highly significant for him and his family, both financially and emotionally.
The Committee stated: "Although the decision of the Committee to remove [Mr Williams] from the Register sent a clear message to the profession of the importance of certification, it should be emphasised that his removal was the consequence of his actions in signing certificates which he could not verify. This followed three previous occasions on which he had similarly signed certificates when he should not have done so."
However, the Committee was satisfied that Mr Williams would not in future sign certificates when he should not do so, even under severe client pressure. It was impressed with the continuing professional development he had undertaken whilst off the Register and noted that no questions had been raised over his conduct during this time.
It concluded that Mr Williams fully understood the importance of accurate certification and that restoring his name to the Register therefore posed no risk to animal welfare. Neither the public nor the profession would benefit from Mr Williams staying off the Register for a further period.
Alison Bruce, Disciplinary Committee Chairman, said: "We would like to make it clear that we always find it distressing to remove clinically competent veterinary surgeons from the Register because of an irresponsible and cavalier attitude towards certification. This would not be necessary if veterinary surgeons were to follow the Twelve Principles of Certification annexed to the RCVS Guide to Professional Conduct."
The Committee then approved Mr Williams' application and directed that his name should be restored to the Register.
Andrew Robathan MP has opened Companion Care Vets latest surgery in Leicester, bringing the number of surgeries across the UK to 67.
The surgery is located within the brand new Pets at Home store at Fosse Park, and the joint veterinary partners are Shabbir Shariff and Sameer Bheda.
The surgery houses a full operating theatre, digital x-ray facilities, in-house laboratory and a hospital ward providing a full range of treatments from health checks to emergency operations.
Shabbir said: "I have always wanted to own my own surgery and jumped at the opportunity to work with Companion Care Vets."
Andrew Groom has been appointed as the new Country Manager for Kruuse UK Ltd based near York, following the promotion of Lars Lund and his relocation back to Kruuse A/S in Denmark. Andrew takes up this new position to head up the UK sales and marketing team and to help implement the expansion programme within the veterinary and pet markets that Kruuse has planned for 2008.
Having studied agriculture and gaining a DHM, Andrew managed large farming operations, as well as being a contributing writer for the agricultural journal “Farmers Weekly”. He then continued his education by studying commercial management at Circencester College from where he went to United Milk as a Farm Liaison manager and commercial manager. His career progressed when in 2004, he joined Arnolds Veterinary Products as sales manager.
“I have known about Kruuse and its wide range of products for many years and have always admired the company’s vision in bringing innovative products onto the market for both the large and small animal sectors, including high quality pet toys and accessories,” said Andrew. “So when an opportunity arose to work for Kruuse in the UK, I did not need much persuading to apply for the job.”
“Andrew’s vast experience in both large and small animal industries will prove a real asset in all of the important market areas in which Kruuse operates,” commented Hans Alsted, Kruuse A/S Export Director.
Vets Now, in cooperation with its host practices and the Veterinary Poisons Information Service, is launching a new 'Tox Box' service giving veterinary surgeons 24 hour direct access to the treatments that they are most likely to need, and least likely to stock, in a poisoning emergency.
Vets Now says this new service represents a significant step forward in the ease and availability of care for the intoxicated patient.
Through Tox Box, any vet calling the VPIS advice line after 31st March 2011 will be able to access the drugs required in a poisoning emergency at selected Vets Now clinics and their host practices across the UK. Drugs will be available at cost, plus a small handling charge.
Amanda Boag, Clinical Director at Vets Now said: "We are delighted to be working in partnership with VPIS to offer vets this life-saving service for pets across the UK.
"As emergency and critical care practitioners we frequently deal with poisoning cases and are pleased to be able to use our clinics to allow vets access to the treatments they need in a hurry.
"Tox Box is a service which has been designed to help enhance the current VPIS advice service whereby vets can now easily gain access to those drugs they are most likely to need to treat toxicities, but not stock internally, such as plasma and Adder anti-venom. The service VPIS provides is very important for vets, and we hope that this additional provision will greatly benefit them and the pets they are caring for."
Alex Campbell, Head of Services at VPIS said: "We are looking forward to working in partnership with Vets Now to improve outcomes for poisoned animals and their owners.
"Poisons can have deadly affects on animals if not treated quickly. Previously vets may have had to call round several hospitals or practices to source the recommended drug whilst their patient's health deteriorates. Through Tox Box we can help them access the drug without delay and provide case-specific guidance to ensure the animal receives optimum care."
The VPIS 24/7 telephone number to ring is: 020 7188 0200
CVS has announced a two year programme of investment of more than £3 million in two high-field (1.5 Tesla) MRI scanners and seven CT scanners as part of a programme to provide advanced imaging resourcing across the group.
The first of the MRI scanners will be installed at ChesterGates, CVS' multi-disciplinary veterinary referral hospital, in Spring 2015. CVS says it believes it will be the most advanced MRI system for pets in the North West of England.
The seven 16-slice CT scanners will be installed at CVS hub practices, including ChesterGates, PetMedics in Manchester, Beechwood Veterinary Hospital in Doncaster and St David's in Devon.
CVS Referral Director John Innes said: "We are committed to utilising the latest technology across the group and this investment in our scanning capability is a good example. The new MRI scanner at ChesterGates will enhance the high quality specialist referral services we offer, particularly in neurology because MRI is used mainly to image the brain and spinal cord.
"The seven new CT scanners will enable our teams to scan a chest or abdomen rapidly and with outstanding image quality. Image data can be processed and viewed in other planes or 3-D rendered to assist with decision making and surgical planning. The installation of the new CT scanners will be rolled out over the next two years, enabling us to offer cost-effective advanced imaging to many more of our clients across the country."